Enanta Pharmaceuticals Inc. sell JPMorgan Chase & Co.
Start price
09.08.23
/
50%
€14.70
Target price
09.08.24
€12.75
Performance (%)
-25.17%
End price
10.08.24
€11.00
Summary
This prediction ended on 10.08.24 with a price of €11.00. The price of Enanta Pharmaceuticals Inc. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -25.17%. JPMorgan_Chase___Co_ has a follow-up prediction for Enanta Pharmaceuticals Inc. where he still thinks Enanta Pharmaceuticals Inc. is a Sell. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Enanta Pharmaceuticals Inc. | 8.840% | 8.840% | -3.431% |
| iShares Core DAX® | -1.471% | 1.895% | 25.178% |
| iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
| iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
| iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $14.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat
In the thread Trading Enanta Pharmaceuticals Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.50
06.08.24
06.08.24
€9.15
06.08.25
06.08.25
-14.35%
03.10.24
03.10.24
